xcess adiposity is a well-established risk factor for premature death in the general population, including death due to cardiovascular disease or cancer. [1] [2] [3] [4] However, a so-called obesity paradox (i.e., an association between obesity, as compared with normal weight, and reduced mortality) has been reported among patients with heart failure, end-stage renal disease, or hypertension, and, recently, among those with type 2 diabetes. [5] [6] [7] [8] [9] [10] [11] [12] Most of these studies, however, have been limited by small samples and suboptimal control for smoking status and preexisting chronic conditions.
Smoking is a concern in analyses of body weight and mortality because it is associated with decreased body weight but an increased risk of death. 13 Statistical adjustment for smoking status (e.g., ever smoked vs. never smoked) is often insufficient to control for varying degrees of smoking duration and intensity. Thus, stratification according to smoking status can be an important way to examine the association between body weight and the risk of death; in addition, the subgroup analysis among persons who have never smoked can reduce residual bias related to smoking. 3, 4, [13] [14] [15] An additional concern is reverse causation, whereby underlying chronic disease or frailty both causes weight loss and elevates the risk of death. Exclusion of persons with known illnesses at baseline and censoring of data for patients who died early in the follow-up period are routinely performed to reduce this bias. 16 To address the limitations of previous analyses, we conducted a detailed analysis of the association between body-mass index (BMI) and the risk of death among participants with incident diabetes from two large prospective cohort studies, the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS).
Me thods

Study Population
The NHS was initiated in 1976 with the enrollment of 121,700 female nurses 30 to 55 years of age. The HPFS began in 1986, enrolling 51,529 male health professionals between 40 and 75 years of age. Questionnaires are administered biennially to update medical, lifestyle, and other health-related information. 17, 18 Cumulative follow-up exceeds 90% of potential person-time for both cohorts.
Our analyses included women and men reporting incident diabetes between baseline (1976 for the NHS and 1986 for the HPFS) and January 1, 2010 (Fig. S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org).
We excluded participants reporting a history of diabetes at baseline or reporting cardiovascular disease (stroke, coronary heart disease, or coronaryartery bypass graft surgery) or cancer before a diabetes diagnosis. Participants were excluded if they were underweight (BMI [the weight in kilograms divided by the square of height in meters] <18.5, because of limited statistical power for this group), had received a diagnosis of diabetes before 35 years of age (probably type 1 diabetes), or did not report body weight on the relevant questionnaire. The study protocol was approved by the institutional review boards of Brigham and Women's Hospital and the Harvard School of Public Health, with participants' consent implied by the return of the questionnaires. The first, second, and last authors take complete responsibility for the integrity of the data and the accuracy of the data analysis.
Assessment of Type 2 Diabetes
Participants reporting a physician's diagnosis of diabetes on the biennial questionnaire were mailed a supplemental questionnaire. Confirmed cases were defined according to the National Diabetes Data Group classification, 19 updated in June 1998 to adopt a new threshold for a fasting plasma glucose level of at least 126 mg per deciliter (7.0 mmol per liter). 20 Validation studies with the use of medical records for 62 NHS participants 21 and 59 HPFS participants 22 showed very high accuracy of our classification (98% and 97%, respectively).
Assessment of Body-Mass Index
Body weight was updated every 2 years by questionnaire. Weight at diagnosis was estimated from the most recent questionnaire before the diagnosis (mean time from questionnaire to diagnosis, 11 months). 
Ascertainment of Deaths
The primary outcome was death from any cause through January 1, 2012. Most deaths (>98%) were identified from reports by the next of kin or postal authorities or from searches of the National Death Index. 
Assessment of Covariables
Detailed information on cigarette smoking, physical activity, menopausal status (for NHS participants only), and several lifestyle factors and health outcomes were updated every 2 years. Marital status and status with respect to a family history of diabetes were assessed periodically. Dietary information was collected from validated foodfrequency questionnaires approximately every 4 years. Diet quality was assessed with the use of the 2010 Alternate Healthy Eating Index (with scores ranging from 2.5 to 87.5 and higher scores indicating a healthier diet). 26 The covariables were derived from the most recent questionnaire before a diabetes diagnosis.
Statistical Analysis
Hazard ratios and 95% confidence intervals were estimated from Cox proportional-hazards models, with number of months since a diabetes diagnosis as the time scale. Person-time was calculated from the date of a diabetes diagnosis until death or the end of follow-up (January 1, 2012 27 A P value of less than 0.05 was considered to indicate a significant linear or nonlinear trend. The hazard-ratio estimates for the two cohorts were combined with the use of fixed-effect metaanalyses with inverse-variance weighting. We repeated our analyses with stratification according to baseline smoking status and with early deaths (<4 years after diagnosis) excluded. Effect modification by smoking status (never smoked vs. ever smoked) and age at diagnosis (<65 years vs. ≥65 years) was estimated from the multiplicative interaction term between continuous BMI and the effect modifier added to the main effects model. The proportional-hazards assumption was evaluated with a likelihood-ratio test comparing the model with and without an interaction term between time period and BMI category. Data were analyzed with the use of SAS software, version 9.2 (SAS Institute), at a two-tailed alpha level of 0.05.
R esult s
Study Participants
For the 11,427 participants included in our analysis, the mean age at diabetes diagnosis was 62 years (range, 35 to 86) among the 8970 NHS participants and 64 years (range, 41 to 91) among the 2457 HPFS participants. Baseline characteristics are presented in Table 1 , stratified according to BMI categories. A higher BMI at diagnosis was inversely associated with age at diagnosis, physical activity, and Alternate Healthy Eating Index score. The lowest BMI category (18.5 to 22.4) had the highest prevalence of current smokers, and normal-weight participants (BMI, 18.5 to 24.9) were more likely to have lost weight before diagnosis than overweight participants (BMI, 25.0 to 29.9) and obese participants (BMI, ≥30).
A total of 3083 deaths from all causes were observed over a mean follow-up of 15.8 years, with a maximum follow-up of 36 years among women (mean, 16.2 years; 16.1 deaths per 1000 personyears) and 26 years among men (mean, 14.5 years; 21.8 deaths per 1000 person-years). The mean (±SD) age at death was 74.6±7.8 years for women and 78.7±8.7 years for men. In general, crude rates of death were higher among participants who had ever smoked than among those who had never smoked, across BMI categories (Table 2) .
A J-shaped association between BMI and allcause mortality was observed among all the participants (Table 2 ) (P<0.001 for nonlinearity among NHS participants; P = 0.59 among HPFS participants). As compared with participants with a BMI of 22.5 to 24.9, those in the lowest BMI category, 18.5 to 22.4, had a significantly elevated all-cause mortality (hazard ratio, 1.29; 95% confidence interval [CI], 1.05 to 1.59), as did those in the highest BMI categories (BMI of 30.0 to 34.9: hazard ratio, 1.24; 95% CI, 1.08 to 1.42; BMI ≥35.0: hazard ratio, 1.33; 95% CI, 1.14 to 1.55).
Results indicated significant effect modification according to smoking status ( Table 2 ) (P = 0.04 for interaction), with divergent trends in the risk of death across BMI strata for participants who had ever smoked as compared with those who had never smoked. A sig nificant linear trend was seen among participants who had never smoked (P<0.001), with no evidence of a nonlin- ear trend (P = 0.41 for NHS participants; P = 0.22 for HPFS participants). Among participants who had ever smoked, however, there was a nonlinear J-shaped trend in the combined cohort of men and women and in the cohort of women (P<0.001 for NHS participants) but not in the cohort of men (P = 0.72 for HPFS participants). Significant effect modification according to age at diagnosis was observed (P<0.001 for interaction) (Table S1 in the Supplementary Appendix). Among adults younger than 65 years of age at diagnosis, there was a direct linear relationship between BMI and all-cause mortality (P<0.001 for linear trend among total participants, those who had never smoked, and those who had ever smoked). In contrast, a direct linear trend among participants 65 years of age or older at diagnosis was observed only among those who had never smoked (P = 0.04), and among participants who had ever smoked, a significantly increased risk of death was observed only in the lowest BMI category (hazard ratio, 1.89; 95% CI, 1.32 to 2.71).
The results of the analyses that assessed residual confounding by smoking status and reverse causation are depicted in Figures 1A through 1F. Exclusion of participants who died in 239 the first 4 years of follow-up (a total of 227 participants: 78 who had never smoked and 149 who had ever smoked) (Fig. 1B, 1D , and 1F, respectively) resulted in a monotonic positive association between BMI and death among participants who had never smoked, and the results did not differ substantially from those of the primary analysis. Exclusion of participants with weight loss of more than 1 BMI unit before a diabetes diagnosis, adjustment for baseline hypertension or hypercholesterolemia, and adjustment for year of diabetes diagnosis produced similar results (data not shown 
Cause-Specific Mortality
We assessed the relationship between BMI just before a diabetes diagnosis and deaths due to cardiovascular disease (941 deaths), cancer (784 deaths), and other causes (e.g., respiratory diseases, renal disease, suicide, and accidents; 1358 deaths) ( Fig. 2A, 2B , and 2C; and Table S4 in the Supplementary Appendix). There was a significant direct linear relationship between BMI and cardiovascular mortality among all participants (P<0.001 for linear trend) and among those who had never smoked (P = 0.004), but the relationship appeared to be attenuated among those who had ever smoked (P = 0.02). In the lowest BMI category (18.5 to 22.4), a significant increase in cancer mortality was seen among all participants (hazard ratio, 1.51; 95% CI, 1.00 to 2.28) and among those who had ever smoked (hazard ratio, 1.87; 95% CI, 1.15 to 3.04) but not among those who had never smoked (hazard ratio, 0.83; 95% CI, 0.34 to 2.05). The relationship between BMI and mortality from other causes appeared to be J-shaped for all participants.
Discussion
Our analyses of data from two large, long-term, prospective cohort studies indicate a J-shaped as- sociation between BMI immediately before a diagnosis of type 2 diabetes and all-cause mortality. This relationship was linear among participants who had never smoked but was nonlinear among those who had ever smoked. We did not observe a benefit of excess adiposity with regard to the risk of death; thus, our findings support the current recommendation that patients with diabetes achieve or maintain a normal weight. 28 Although our findings are largely consistent with the results of previous analyses in the general population, 1-4 they contradict the results of several studies of BMI and mortality among participants with diabetes. Prior studies largely suggest inverse, 10 J-or U-shaped, 11, 29, 30 or flat or null associations 9,31 ; however, notable limitations include a short follow-up duration, 9,11,30 a small number of deaths, 10,29,31,32 and a lack of analyses assessing biases from smoking or undiagnosed chronic diseases. [9] [10] [11] [29] [30] [31] [32] The majority of these studies involved patients who already had diabetes, with BMI assessed up to several decades after the diagnosis; these factors substantially increase susceptibility to reverse-causation bias. 9, [29] [30] [31] [32] Recently, Carnethon et al. 10 analyzed pooled data from five large U.S. cohorts and concluded that adults who were of normal weight at the time of a diabetes diagnosis had a risk of death that was twice as high as that among their overweight or obese counterparts (hazard ratio, 2.01; 95% CI, 1.44 to 2.81); however, several of the limitations outlined above apply to this study. Relatively low statistical power (449 total deaths) limited their BMI classification to two broad and heterogeneous exposure groups (participants with a BMI of 18.5 to 24.9 and those with a BMI ≥25.0). Subgroup analyses were also underpowered, such that conclusions could not be drawn. In addition, BMI was measured after the diabetes diagnosis for many participants, allowing additional bias from the initiation of diabetes treatment or the progression of other underlying illnesses. 10 The attenuated relationship between BMI and mortality among smokers has frequently been observed in the general population. 3, 4, 14, 15 It is unclear whether this effect modification represents biologic differences between smokers and nonsmokers or is largely due to bias. 13 Additional studies are needed to answer this question.
In our study, effect modification according to age at diagnosis indicated a direct linear trend among participants younger than 65 years of age but a null or weakened linear association among participants 65 years of age or older. These findings, which are consistent with the results of previous studies involving participants with type 2 diabetes 32 and the general population, 1,33 may reflect well-known limitations in analyses of mortality among older persons, including an increased prevalence of coexisting chronic diseases, which increases the potential for reverse-causation bias; an increased prevalence of competing risk factors, which reduces the proportional effect of a single factor; and decreased validity of BMI as a measure of adiposity owing to age-related declines in muscle mass and wasting. 34 It has also been suggested that excess adiposity may confer a metabolic advantage and improved survival among the elderly. Therefore, caution should be taken in interpreting the results among the older participants.
Our findings with respect to the relationship between BMI and mortality due to specific causes are consistent with those of prior studies conducted in the general population. [2] [3] [4] 14, 15 Among participants who had never smoked, the relationship of BMI to both cardiovascular mortality and cancer mortality appeared to be monotonic and linear. No significant association was observed between any BMI category and the risk of death from cardiovascular disease among participants who had ever smoked; however, participants in the lowest BMI category who had ever smoked had a significantly elevated risk of death from cancer.
Proposed biologic mechanisms of the alleged obesity paradox include an increased genetic influence and more severe diabetes among normal-weight persons with diabetes or the effect of a "metabolically obese normal weight" phenotype. 35, 36 However, normal-weight participants in our cohort were no more likely to report diabetes symptoms or coexisting chronic diseases or to require insulin than were overweight or obese participants. In contrast, normal-weight participants were more likely to be smokers and to have lost weight before a diagnosis of diabetes. Comparisons with this heterogeneous normal-weight group may therefore underestimate the risk of death among the overweight and obese.
Strengths of our study include the large sample (3083 deaths among 11,427 adults with incident diabetes), permitting detailed exami-241 Hazard Ratio nation across multiple BMI categories and key analyses to address potential biases. Prospectively measured body weight, documented just before or at the time of a diabetes diagnosis, prevents misclassification from weight change due to early pharmacologic treatments or lifestyle changes shortly after diagnosis. Enrollment of health professionals has proved beneficial with respect to the reliability and validity of self-reported health-related exposures and outcomes, and it reduces confounding by educational and socioeconomic factors. Limitations of the study include the reliance on self-reported weight measures, although erroneous reporting was shown to be very minimal in validation studies, and corrections of errors in BMI measurement produced similar findings. Information on weight was obtained an average of 11 months before diagnosis as a proxy for the weight at diagnosis, but this is unlikely to have resulted in appreciable error. Finally, the relative homogeneity of the NHS and HPFS cohorts may limit the generalizability of our findings to other racial and ethnic groups.
In conclusion, our results indicate a J-shaped relationship between BMI at the time of a diabetes diagnosis and the risk of death from all causes, with the lowest risk observed among normal-weight participants with a BMI of 22.5 to 24.9. Among participants who had never smoked, there was a direct linear relationship between BMI and mortality, whereas a nonlinear relationship was observed among those who had ever smoked. There was no evidence of a protective effect of overweight or obesity on mortality. In addition, given the relationship of overweight and obesity to other critical public health end points (e.g., cardiovascular disease and cancer), the maintenance of a healthy body weight should remain the cornerstone of diabetes management, irrespective of smoking status. Further evidence is needed to corroborate our findings in other populations.
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